on-invasive cardiac screening in patients with peripheral arterial disease: the GROUND study.
Recruiting
- Conditions
- peripheral arterial diseaseFontaine II and upcoronary artery stenosis
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 1200
Inclusion Criteria
1. PAD patients, stage Fontaine II (intermittent claudication) diagnosed by the vascular surgeon;
2. Patients must provide consent in writing after proper education and discussion with the treating physician and/or research physician;
Exclusion Criteria
1. History of symptomatic cardiac disease;
2. Cardiac rhythm other than sinus;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatal and non-fatal myocardial infarction and stroke, and vascular death (death due to vascular disease).
- Secondary Outcome Measures
Name Time Method 1. Fatal and non-fatal myocardial infarction; <br /><br>2. Fatal and non-fatal stroke;<br /><br>3. Vascular interventions;<br /><br>4. Amputation;<br /><br>5. Aortic rupture; <br /><br>6. End stage renal failure;<br /><br>7. Extra cranial hemorrhage;<br /><br>8. Complications of CABG or PTCA;<br /><br>9. All cause mortality.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link peripheral arterial disease to coronary artery stenosis in the GROUND study (NL-OMON26430)?
How does non-invasive cardiac screening compare to coronary angiography for detecting stenosis in PAD patients with Fontaine II classification?
Which inflammatory biomarkers predict response to non-invasive cardiac screening in PAD patients with coronary artery disease?
What adverse events are associated with non-invasive cardiac screening in PAD populations, and how are they managed?
Are there emerging non-invasive imaging modalities or biomarker panels for PAD with coronary artery stenosis beyond the GROUND study (NL-OMON26430)?